Rong Li

1.3k total citations
64 papers, 969 citations indexed

About

Rong Li is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Rong Li has authored 64 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 10 papers in Cell Biology and 8 papers in Oncology. Recurrent topics in Rong Li's work include Rheumatoid Arthritis Research and Therapies (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Rong Li is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Angiogenesis and VEGF in Cancer (5 papers) and Hippo pathway signaling and YAP/TAZ (5 papers). Rong Li collaborates with scholars based in China, United States and Macao. Rong Li's co-authors include Li Cai, Wen Jian Tang, Jing Bo Shi, Xin Hua Liu, Mingming Liu, Meng‐yuan Zhou, Wenjian Tang, Chengmu Hu, Xuefeng Xie and Fang-Yuan Liu and has published in prestigious journals such as PLoS ONE, Cancer Research and Biochemical Journal.

In The Last Decade

Rong Li

56 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rong Li China 19 479 116 114 113 101 64 969
Rikang Wang China 20 512 1.1× 65 0.6× 108 0.9× 122 1.1× 66 0.7× 44 1.0k
Angela Lauriola Italy 10 580 1.2× 52 0.4× 108 0.9× 104 0.9× 112 1.1× 23 1.1k
Jyoti Gautam India 21 610 1.3× 108 0.9× 116 1.0× 82 0.7× 44 0.4× 42 1.2k
Youzhi Xu China 19 507 1.1× 150 1.3× 118 1.0× 180 1.6× 49 0.5× 33 1.1k
Xu Cao China 22 572 1.2× 96 0.8× 195 1.7× 96 0.8× 319 3.2× 53 1.7k
Meriç A. Altinoz Türkiye 21 532 1.1× 59 0.5× 139 1.2× 217 1.9× 99 1.0× 89 1.2k
Ángel Hernández‐Hernández Spain 19 682 1.4× 58 0.5× 117 1.0× 211 1.9× 215 2.1× 49 1.4k
Bryan Harder United States 14 889 1.9× 85 0.7× 98 0.9× 154 1.4× 80 0.8× 16 1.3k
Haili Zhu China 20 667 1.4× 42 0.4× 177 1.6× 137 1.2× 126 1.2× 53 1.3k
Margarita M. Ivanova United States 23 667 1.4× 59 0.5× 181 1.6× 177 1.6× 85 0.8× 59 1.5k

Countries citing papers authored by Rong Li

Since Specialization
Citations

This map shows the geographic impact of Rong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Li more than expected).

Fields of papers citing papers by Rong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Li. The network helps show where Rong Li may publish in the future.

Co-authorship network of co-authors of Rong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Li. A scholar is included among the top collaborators of Rong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Li. Rong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yan, Meng‐yuan Zhou, Lingling Li, et al.. (2025). Bacopaside I, acting as an aquaporin 1 inhibitor, ameliorates rheumatoid arthritis via suppressing aquaporin 1-mediated autophagy. Phytomedicine. 138. 156444–156444. 2 indexed citations
2.
Liu, Xuesong, Lin Li, Feilong Li, et al.. (2025). Eupalinolide B alleviates rheumatoid arthritis through the promotion of apoptosis and autophagy via regulating the AMPK/mTOR/ULK-1 signaling axis. International Immunopharmacology. 148. 114179–114179.
3.
Ouyang, Feng, Fangfang Sun, Da Luo, et al.. (2025). CIDEC Restricts Liver Regeneration by Disturbing Lipid Droplet Triglyceride Turnover. Advanced Science. 13(3). e07048–e07048.
4.
Zhang, Manyu, Meng‐yuan Zhou, Yujie Zhou, et al.. (2025). Acetazolamide as an aquaporin 1 inhibitor mitigates rheumatoid arthritis by reducing angiogenesis via the modulation of the FAK-PI3K/Akt signaling pathway. International Immunopharmacology. 158. 114845–114845.
5.
Li, Rong, et al.. (2025). HNRNPH1 promotes autophagy to inhibit the development of lung adenocarcinoma via the HSP90AB1/MAP1LC3B axis. Respiratory Research. 26(1). 206–206. 1 indexed citations
6.
Wang, Xiao Hua, Tiantian Wang, Yan Huang, et al.. (2024). Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via modulation of the AMPK/mTOR/ULK-1 signaling pathway. Phytomedicine. 128. 155512–155512. 30 indexed citations
8.
Li, Feilong, et al.. (2024). Design, synthesis and biological evaluation of indazole derivatives as VEGFR-2 kinase inhibitors with anti-angiogenic properties. European Journal of Medicinal Chemistry. 279. 116889–116889. 2 indexed citations
9.
Li, Rong, Xuejing Xu, Shuo Gao, et al.. (2023). Circular RNA CDR1as Mediated by Human Antigen R (HuR) Promotes Gastric Cancer Growth via miR-299-3p/TGIF1 Axis. Cancers. 15(23). 5556–5556. 2 indexed citations
10.
Zhang, Xuetao, Hongmei Tang, Linna Wang, et al.. (2023). Catalytic probes based on aggregation-induced emission-active Au nanoclusters for visualizing MicroRNA in living cells and in vivo. Analytica Chimica Acta. 1268. 341372–341372. 9 indexed citations
11.
Chen, Qingling, Wei He, Fei Jiang, et al.. (2023). Discovery of highly potent and selective VEGFR2 kinase inhibitors for the treatment of rheumatoid arthritis. European Journal of Medicinal Chemistry. 257. 115456–115456. 7 indexed citations
12.
Meng, Yan, Qiudong Zhao, Liwei An, et al.. (2021). A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells. Cancer Research. 81(11). 3036–3050. 74 indexed citations
16.
17.
Li, Yanling, et al.. (2020). Di-(2-ethylhexyl) phthalate inhibits expression and internalization of transthyretin in human placental trophoblastic cells. Toxicology and Applied Pharmacology. 394. 114960–114960. 15 indexed citations
18.
Shi, Jing Bo, et al.. (2014). Novel pyrazole-5-carboxamide and pyrazole–pyrimidine derivatives: Synthesis and anticancer activity. European Journal of Medicinal Chemistry. 90. 889–896. 101 indexed citations
19.
Li, Rong, Li Cai, Xuefeng Xie, et al.. (2012). 7,3′-dimethoxy hesperetin inhibits inflammation by inducing synovial apoptosis in rats with adjuvant-induced arthritis. Immunopharmacology and Immunotoxicology. 35(1). 139–146. 27 indexed citations
20.
Staunstrup, Nicklas Heine, Juan Li, Ying Liu, et al.. (2012). Development of Transgenic Cloned Pig Models of Skin Inflammation by DNA Transposon-Directed Ectopic Expression of Human β1 and α2 Integrin. PLoS ONE. 7(5). e36658–e36658. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026